Abstract
BackgroundCoexisting fibromyalgia (FM) in axial spondyloarthritis (axSpA) can represent therapeutic challenges, particularly when evaluating the treatment effect of biologics (i.e. TNF alpha blockers (TNFb)). Indeed, since FM patients often report...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have